3.8 Article

Draft Genome Sequence of Streptomyces rapamycinicus Strain NRRL 5491, the Producer of the Immunosuppressant Rapamycin

Journal

GENOME ANNOUNCEMENTS
Volume 1, Issue 4, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/genomeA.00581-13

Keywords

-

Categories

Funding

  1. Government of Slovenia, Ministry of Higher Education, Science and Technology (Slovenian Research Agency, ARRS) [J4-9331, J4-4149]
  2. Croatian Science Foundation, Republic of Croatia [09/5]
  3. German Academic Exchange Service (DAAD)
  4. Ministry of Science, Education and Sports, Republic of Croatia

Ask authors/readers for more resources

Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available